FindTrial
Sign In

Removing a group of lymph nodes in axilla to stage the nodal involvement following chemotherapy in carcinoma breast

Low axillary sampling in predicting nodal status of post-chemotherapy axilla in carcinoma breast

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/028016
Enrollment
78
Registered
2020-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast

Interventions

None listed

Sponsors

INSTITUTIONAL SPONSORRCCTRIVANDRUM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Post chemotherapy node negative axilla in carcinoma breast

Exclusion criteria

Exclusion criteria: 1. Metastatic carcinoma breast 2. Previous axillary surgery

Design outcomes

Primary

MeasureTime frame
To assess the diagnostic accuracy of low axillary sampling to predict the nodal status of post chemotherapy node negative axillaTimepoint: Low axillary sampling done at time of surgery—

Secondary

MeasureTime frame
To assess the role of ultrasound in axillary nodal staging of post chemotherapy axillaTimepoint: 2 years—

Countries

India

Contacts

Public ContactDr Abinaya R N

REGIONAL CANCER CENTER, TRIVANDRUM

dr.abinayanadarajan@gmail.com9842704717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026